Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07007741 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digital Therapy for Fatty Liver Disease

Study acronym: DTFLD
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Mar 31, 2026 → Jul 1, 2026
See other at-risk trials from Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Record History

  1. Primary completion pushed from Mar 31, 2026 to Jul 1, 2026
    • Enrollment increased: 120 → 141 participants
    • Start date: Oct 26, 2023 to Nov 19, 2022
    v3
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Dec 31, 2025 to Mar 31, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is a randomised controlled trial of the clinical application of the Fatty Liver Data Analysis and Intervention System (FLDAS) to compare the effectiveness of traditional lifestyle interventions in patients with fatty liver with digital therapies combining software and hardware devices; to validate the effectiveness of digital therapies in patients with fatty liver; and to evaluate the effectiveness of remote lifestyle (diet and exercise) interventions. Researchers conducted a randomised controlled trial to compare the effectiveness of a traditional lifestyle intervention for patients with fatty liver with a remote lifestyle (diet and exercise) intervention combining digital therapy software and hardware devices. When the effectiveness of this programme is validated, it could help clinicians improve the efficiency of lifestyle interventions for patients with fatty liver and address the growing need for primary care for patients with fatty liver as an innovative approach to disease intervention.
Trial Details
NCT Number NCT07007741
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions
(from sponsor)		 Steatohepatitis, Nonalcoholic, Nonalcoholic Fatty Liver
Related terms Non-alcoholic Fatty Liver Disease
Enrollment 141 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov